Evidence map›Paper›PMID 27328793›Full record

ArticleJournal of oncology practice2016

Innovative Strategies for Decreasing Blood Collection Wait Times for Patients in Early-Phase Cancer Clinical Trials.

Bayabel Mengistu, Dina Ray, Passion Lockett, Vivian Dorsey, Ron A Phipps, Harihara Subramanian, Johnique T Atkins, Badi El Osta, Gerald S Falchook, Daniel D Karp

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Journal of oncology practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Bayabel MengistuThe University of Texas MD Anderson Cancer Center, Houston, TX; Medical College of Georgia, Augusta, GA; and Sarah Cannon Research Institute at HealthONE, Denver, CO.
Dina RayThe University of Texas MD Anderson Cancer Center, Houston, TX; Medical College of Georgia, Augusta, GA; and Sarah Cannon Research Institute at HealthONE, Denver, CO.
Passion LockettThe University of Texas MD Anderson Cancer Center, Houston, TX; Medical College of Georgia, Augusta, GA; and Sarah Cannon Research Institute at HealthONE, Denver, CO.
Vivian DorseyThe University of Texas MD Anderson Cancer Center, Houston, TX; Medical College of Georgia, Augusta, GA; and Sarah Cannon Research Institute at HealthONE, Denver, CO.
Ron A PhippsThe University of Texas MD Anderson Cancer Center, Houston, TX; Medical College of Georgia, Augusta, GA; and Sarah Cannon Research Institute at HealthONE, Denver, CO.
Harihara SubramanianThe University of Texas MD Anderson Cancer Center, Houston, TX; Medical College of Georgia, Augusta, GA; and Sarah Cannon Research Institute at HealthONE, Denver, CO.
Johnique T AtkinsThe University of Texas MD Anderson Cancer Center, Houston, TX; Medical College of Georgia, Augusta, GA; and Sarah Cannon Research Institute at HealthONE, Denver, CO.
Badi El OstaThe University of Texas MD Anderson Cancer Center, Houston, TX; Medical College of Georgia, Augusta, GA; and Sarah Cannon Research Institute at HealthONE, Denver, CO.
Gerald S FalchookThe University of Texas MD Anderson Cancer Center, Houston, TX; Medical College of Georgia, Augusta, GA; and Sarah Cannon Research Institute at HealthONE, Denver, CO.
Daniel D KarpThe University of Texas MD Anderson Cancer Center, Houston, TX; Medical College of Georgia, Augusta, GA; and Sarah Cannon Research Institute at HealthONE, Denver, CO dkarp@mdanderson.org.
Augusta University · USThe University of Texas MD Anderson Cancer Center · USHealthONE · USSarah Cannon · US

Funding

Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
NCATS NIH HHS UL1 TR000371
6 · The paper itself

Abstract

purposeLong wait times are a primary source of dissatisfaction among patients enrolled in early-phase clinical trials. We hypothesized that an automated patient check-in system with readily available display for increasing awareness of waiting intervals would improve patient flow and use of our rooms, with decreased turnover time and increased throughput.

methodsWe recorded in-room wait times for patients seen in our clinic and observed the logistics involved in the blood collection process to delineate causes for delays. We then implemented a three-step strategy to alleviate the causes of these delays: (1) changing the collection of materials and the review of faxed orders, (2) improving our LabTracker automated database system that included wait time calculators and real-time information regarding patient status, and (3) streamlining lower complexity appointments.

resultsAfter our intervention, we observed a 19% decrease in mean wait times and a 30% decrease in wait times among patients waiting the longest (95th percentile). We also observed an increase in staff productivity during this process. Modifications in LabTracker provided the biggest reduction in mean wait times (17%).

conclusionWe observed a significant decrease in mean wait times after implementing our intervention. This decrease led to increased staff productivity and cost savings. Once wait times became a measurable metric, we were able to identify causes for delays and improve our operations, which can be performed in any patient care facility.

Indexed as

Efficiency, OrganizationalBlood Specimen CollectionClinical Trials as TopicHumansNeoplasmsPatient SatisfactionTime Factors

Identifiers

PMID27328793
PMCPMC6366248
OpenAlexW2472060464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.